BOSTON -- Investigational crinecerfont reduced the need for glucocorticoids in adults and kids with congenital adrenal hyperplasia (CAH), two phase III trials found. In the adult trial of 182 ...

NCAH is when your body doesn’t have enough 21-hydroxylase enzymes to make adrenal hormones. Learn about the causes, symptoms, and treatment for this condition.

Learn about a new drug for classic congenital adrenal hyperplasia (CAH). A top expert explains crinecerfont and its benefits, how it works, and its impact on CAH treatment.

The US Food and Drug Administration has approved crinecerfont for treating congenital CAH in combination with glucocorticoids.

Congenital adrenal hyperplasia (CAH) is a disorder that affects the adrenal gland's ability to release hormones that regulate the body's response to stress and illness.

Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and ...

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by defects in adrenal steroid biosynthesis. The most common form, accounting for 90% of CAH cases, is caused ...

Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, such as cortisol, aldosterone and ...

Classic congenital adrenal hyperplasia is a rare genetic condition affecting the adrenal glands, which produce hormones such as cortisol and androgens.

CRENESSITY, the first new treatment available in 70 years to the classic congenital adrenal hyperplasia (CAH) community, offers a paradigm-shifting treatment approach FDA approval supported by ...

The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), the agency announced late Friday. Crinecerfont was approved for use in ...

About Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones ...